対話型分析
マクロ分析
個別銘柄
アルファラボ
ユーティリティ
Menu
マイアクティビティ
JA
ログイン
JA
急騰分析
/
Drugs Made In America Acquisition Corp.
/
2026-07-21
▲ SURGE
Drugs Made In America Acquisition Corp.
+54.5%
DMAAR
NASDAQ
2026-07-21
0.17
終値
0.11
前日終値
+54.45%
騰落率
65.8x
出来高比
急騰の理由
2026년 5월 5일, Drugs Made In America Acquisition Corp.은 PAGC와의 합병 계약(Merger Deal)을 발표하였다.
·
2026년 5월 5일, Drugs Made In America Acquisition Corp.은 PAGC와의 합병 계약(Merger Deal)을 발표하였다.
関連ニュース
Drugs Made In America Acquisition Announces PAGC Merger Deal
Tipranks
2026-05-05
Larimar stock surges on FDA breakthrough status (LRMR:NASDAQ)
Seekingalpha
2026-02-24
TherapeuticsMD Inc. stock outperforms competitors on strong trading day
Marketwatch
2026-05-18
HC Wainwright & Co. Assumes Larimar Therapeutics at Buy, Announces Price Target of $10 - Larimar Therapeu
Benzinga
2026-07-02
Meadowbrook Advisors Group LLC Purchases New Holdings in Applied Materials, Inc. $AMAT
Zolmax
2026-06-20
テクニカル分析
シグナル
BB上抜け
買われすぎ
MACD強気
SMA20上
主要指標
72.12
RSI (14)
0.11
SMA 20
0.08
Bollinger Lower
0.14
Bollinger Upper
0.11
Bollinger Mid
0.00
MACD
0.00
MACD Signal
0.00
MACD Hist
銘柄詳細を見る
急騰銘柄一覧へ
ホーム
チャット
資産
履歴
メニュー
Drugs Made In America Acquisition Corp. +54.5% 急騰分析 (2026-07-21) | Alpha Lenz